Clinical Trials

224 enrolled

Adenocarcinoma Of Esophagus

NCT06712316 2026-04-15

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

1,260 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03081143 2026-04-14

RAMIRIS

429 enrolled

Advanced Gastric or EGJ Cancer

NCT07063745 2026-04-07

MountainTAP-29

590 enrolled

Lung Neoplasms

NCT02135042 2026-04-03

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

685 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT03315364 2026-04-01

OPTIMAL

549 enrolled

Breast Neoplasms, Recurrence

NCT06926868 2026-04-01

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

500 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02502266 2026-03-05

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

582 enrolled 21 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07131319 2026-02-02

SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05800015 2026-01-22

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

950 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06161025 2026-01-12

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

860 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02101788 2025-11-13

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

260 enrolled 20 charts

Cystadenocarcinoma, Serous

NCT05870748 2025-09-23

REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

600 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

130 enrolled 8 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT06321068 2025-08-14

BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer

5 enrolled

Endometrial Neoplasms

NCT05002127 2025-08-07

A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

127 enrolled

Stomach Neoplasms

NCT05506943 2025-04-20

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

150 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT01779206 2025-04-08

ADAPT

4,936 enrolled

Breast Neoplasms

NCT06123884 2025-02-10

BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

526 enrolled

Uterine Cervical Neoplasms

NCT04499924 2025-01-22

MOUNTAINEER-02

17 enrolled 23 charts

Adenocarcinoma Of Esophagus

NCT05747794 2024-12-17

AIPAC-003

849 enrolled

Breast Neoplasms

NCT05889390 2024-12-03

NeoHTerMa

71 enrolled

Hyperthermia, Breast Neoplasms

NCT05255653 2024-11-29

RAINBO

1,615 enrolled

Endometrial Neoplasms

NCT03721744 2024-04-03

A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer

336 enrolled

Pancreatic Neoplasms

NCT06221748 2024-04-03

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

90 enrolled

Stomach Neoplasms

NCT05189535 2024-01-23

"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

66 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04864782 2024-01-12

QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer

46 enrolled

Uterine Cervical Neoplasms

NCT05427383 2023-12-19

KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy

286 enrolled

Stomach Neoplasms

NCT02221999 2023-08-29

SHPD002

250 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT00245154 2023-08-04

Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer

296 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03150576 2022-11-14

PARTNER

780 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01057069 2022-10-12

neo-TN

310 enrolled

Breast Neoplasms

NCT00997906 2022-09-29

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

Phase 2/3 Not yet recruiting

172 enrolled

Head & Neck

Head and Neck Neoplasms

NCT05489848 2022-08-05

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

294 enrolled

Endometrial Neoplasms

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT05189067 2022-01-12

Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer

190 enrolled

HER2-positive Breast Cancer

NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

469 enrolled 16 charts

Endometrial Adenocarcinoma

NCT04576143 2021-08-12

Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

260 enrolled

HER2-negative Breast Cancer

NCT03580395 2021-07-09

Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer

200 enrolled

Breast Neoplasms

NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2/3 Withdrawn

Esophageal Squamous Cell Carcinoma

NCT04753177 2021-02-15

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

120 enrolled

The Neoadjuvant Therapy

NCT04435652 2020-06-17

A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.

492 enrolled

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

NCT00006229 2020-04-06

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

774 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02279134 2020-04-03

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

360 enrolled

Esophageal Neoplasms

NCT02741856 2018-10-25

SCOPE2

584 enrolled

Esophageal Neoplasms

NCT02651610 2017-07-11

Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

4 enrolled

Esophageal Neoplasms

NCT01572727 2017-03-09

BELLE-4

416 enrolled 11 charts

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT01383148 2017-01-05

TIME

222 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00689715 2016-07-26

EUS-EP